ImmunoScape Pte. Ltd.
- Co-Founder and CEO：
- Ng Choon Peng
Enabling immunotherapy through high-dimensional immune profiling
ImmunoScape is a market-leading biotech company offering state-of-the-art immune profiling services and analytical tools. Their technology offers unprecedented immunological insights that underpin the development of immunotherapies for indications ranging from cancer to infectious and autoimmune diseases to the pharmaceutical industry.
ImmunoScape was founded in December 2016 with the technology licensed from Dr Evan Newell’s laboratory at the Singapore Immunology Network in A*STAR.
ImmunoScape employs cutting-edge technologies and mass cytometry to measure alterations of immune cells and in particular, antigen specific T cells specificity for biomarker and target identification, offering valuable insights on efficacy & safety of immunotherapies in R&D and clinical phase.
UTEC’s value add
UTEC supports ImmunoScape in academic collaborations (especially with the University of Tokyo), business development and team-building strategy.
Immunological insights provided by ImmunoScape
Map of immune response landscape